MicroRNA Market (Product & Service - Profiling, Localization, and Quantification; Application - Cancer, and Neurological Disease; End User - Pharma & Biotech Companies, Academic & Research Institutes, Healthcare Facilities, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

A recent report published by Infinium Global Research on microRNA market provides in-depth analysis of segments and sub-segments in the global as well as regional microRNA market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional microRNA market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global microRNA market.

Market Insight:

The global microRNA market was valued at USD 1224.89 million in 2022 and is expected to reach USD 2977.79 million in 2030, with a CAGR of 12.25% during the forecast period 2023-2030.

Very small RNA molecules called microRNAs, or miRNAs, are essential for controlling the expression of genes. They can bind to messenger RNAs (mRNAs), which prevents them from making proteins. They are smaller than other forms of RNA. The investigation of microRNAs for their potential in the detection and treatment of cancer has attracted a lot of interest in the field of cancer research. Most miRNAs are produced through the transcription of DNA sequences into primary miRNAs, precursor miRNAs, and finally mature miRNAs. When researching the gene lin-14 in Caenorhabditis elegans, Victor Ambros' team discovered microRNA (miRNA) in 1993. The use of microRNAs (miRNAs) in the detection and management of ovarian cancer has shown promising benefits. They are desirable for ovarian cancer research due to their special qualities, which include stability in many biological samples and dysregulated expression in cancer.

The factors which drive the growth of the market, it is experiencing growth as more clinical trials for chronic diseases are conducted. These diseases' onset and progression have been linked to miRNAs. The market for miRNA-based goods and services is driven by the need for precise and early diagnosis, as well as for tailored therapeutics. Additionally, the demand for miRNA-based diagnostics and therapies is being driven by the shift toward personalized medicine, which aims to provide individualized patient care based on molecular profiles. The factor which restrains the market growth is safety and toxicity issues in the services. The advancement in the technology creates an opportunity in the market, the discovery of novel miRNAs, identification of miRNA targets, and characterization of miRNA function are all made possible by next-generation sequencing (NGS) techniques, which enable quick and affordable profiling of miRNA expression patterns.

On the basis of the region, the market is segmented into North America, Europe, Asia Pacific, and ROW. North America is to experience a significant share in the region segment exploring novel therapies and diagnostics is being fueled by an increase in clinical trials, especially in the USA. Additionally, the presence of the major market participants in the area also contributes to the market's expansion. The Asia Pacific region may experience the fastest growth rate. The prevalence of diseases like cancer, cardiovascular conditions, and infectious diseases is particularly high in the Asia Pacific area. Due to this, there is an increasing need for specialized diagnostic techniques and treatments. MiRNAs can diagnose and give treatment in the area due to their potential as disease-specific biomarkers and therapeutic targets.

Report Scope of the MicroRNA Market:

Segment Covered

The report on provides a detailed analysis of segments in the market based on Product & Service, Application, and End User.

Segmentation Based on Product & Service

·       Pharma & Biotech Companies

·       Academic & Research Institutes

·       Healthcare Facilities

·       Others

Segmentation Based on Application

·       Pharma & Biotech Companies

·       Academic & Research Institutes

·       Healthcare Facilities

·       Others

Segmentation Based on End User

·       Pharma & Biotech Companies

·       Academic & Research Institutes

·       Healthcare Facilities

·       Others

Companies Profiled:

·       Merck KGaA

·       Thermo Fisher Scientific Inc.

·       Horizon Discovery Ltd.

·       QIAGEN

·       GeneCopoeia, Inc.

·       New England Biolabs

·       Quantabio

·       NanoString Technologies, Inc.

·       BioGenex

·       SeqMatic LLC.

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the microRNA market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.